Early research (Phase 1)WithdrawnNCT02757248What this trial is testingPh1 Volasertib Plus Romidepsin in R/R PTCL and CTCLWho this might be right forPTCLCTCL Anne Beaven, MD
Not applicableNot Yet RecruitingNCT06651203What this trial is testingEvaluation of the KIR3DL2 Marker in Flow Cytometry for Sézary Syndrome Diagnosis, Therapeutic Response and Residual Disease: a Prospective and Multicenter StudyWho this might be right forMycosis Fungoides/Sezary SyndromeCutaneous T Cell Lymphoma Assistance Publique - Hôpitaux de Paris 460
Not applicableStudy completedNCT01053494What this trial is testingMassage Therapy Given by Caregiver in Treating Quality of Life of Young Patients Undergoing Treatment for CancerWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAcute Undifferentiated LeukemiaAngioimmunoblastic T-cell Lymphoma+84 more Wake Forest University Health Sciences 80
Not applicableStudy completedNCT00014482What this trial is testingMusic Therapy to Ease Pain and Emotional Distress in Patients With Hematologic Cancer Who Are Undergoing High-Dose Therapy and Stem Cell TransplantationWho this might be right forAnxiety DisorderChronic Myeloproliferative DisordersDepression+4 more Memorial Sloan Kettering Cancer Center
Very early researchNot Yet RecruitingNCT07213882What this trial is testingA Phase 1, Multicenter, Open-label, Prospective, First-in-human Dose-escalation Clinical Trial of Domain Therapeutics' Anti-CCR8 Monoclonal Antibody (DT-7012) in Patients With Relapsed or Refractory Cutaneous T-cell Lymphomas (CTCL)Who this might be right forCutaneous T Cell Lymphoma (CTCL)Mycosis FungoidesSezary Syndrome Assistance Publique - Hôpitaux de Paris 30
Not applicableStudy completedNCT05886478What this trial is testingA Study in Adults With Cutaneous T-cell Lymphoma (CTCL) Retreated With Brentuximab VedotinWho this might be right forT-Cell Lymphoma Takeda 26
Early research (Phase 1)Study completedNCT03458117What this trial is testingT-VEC in Non-melanoma Skin CancerWho this might be right forNon-melanoma Skin CancerBasal Cell CarcinomaSquamous Cell Carcinoma+2 more University of Zurich 26
Not applicableWithdrawnNCT01558778What this trial is testingMechanical Stimulation in Preventing Bone Density Loss in Patients Undergoing Donor Stem Cell TransplantWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+100 more Roswell Park Cancer Institute
Early research (Phase 1)Study completedNCT03905135What this trial is testingInterleukin-15 (IL-5) in Combination With Avelumab (Bavencio) in Relapsed/Refractory Mature T-cell MalignanciesWho this might be right forPeripheral T-cell Lymphoma NOSMycosis FungoidesSezary Syndrome+1 more National Cancer Institute (NCI) 8
Testing effectiveness (Phase 2)Study completedNCT01258998What this trial is testingStudy of Akt Inhibitor MK2206 in Patients With Relapsed LymphomaWho this might be right forAdult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+33 more National Cancer Institute (NCI) 60
Testing effectiveness (Phase 2)Study completedNCT00006225What this trial is testingPeripheral Stem Cell Transplantation in Treating Patients With Breast Cancer or Hematologic CancerWho this might be right forBreast CancerLeukemiaLymphoma+2 more Northwestern University
Testing effectiveness (Phase 2)Study completedNCT00744991What this trial is testingParticipants With Relapsed Cutaneous T-Cell LymphomaWho this might be right forCutaneous T-Cell Lymphoma Eli Lilly and Company 25
Early research (Phase 1)Study completedNCT00002625What this trial is testingTopotecan and Radiation Therapy in Treating Patients With Solid Tumors or LymphomaWho this might be right forEsophageal CancerLung CancerLymphoma National Cancer Institute (NCI) 5
Testing effectiveness (Phase 2)WithdrawnNCT00226993What this trial is testingPhase I/II Study of Intratumoral Injection of CPG 7909, a TLR9 Agonist, Combined With Local Radiation for Patients With Recurrent Mycosis Fungoides.Who this might be right forMycosis Fungoides Stanford University
Early research (Phase 1)Study completedNCT00003993What this trial is testingBryostatin 1 and Interleukin-2 in Treating Patients With Refractory Solid Tumors or LymphomaWho this might be right forLymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific National Institute on Aging (NIA) 24
Not applicableStudy completedNCT02652715What this trial is testingSalvia Hispanica Seed in Reducing Risk of Disease Recurrence in Patients With Non-Hodgkin LymphomaWho this might be right forAdult Nasal Type Extranodal NK/T-Cell LymphomaAdult T-Cell Leukemia/LymphomaAnaplastic Large Cell Lymphoma+29 more Mayo Clinic 29
Early research (Phase 1)Study completedNCT00004904What this trial is testingStem Cell Transplantation in Treating Patients With Hematologic CancerWho this might be right forChronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+5 more Northwestern University
Early research (Phase 1)Active Not RecruitingNCT01815749What this trial is testingGenetically Modified T-cell Infusion Following Peripheral Blood Stem Cell Transplant in Treating Patients With Recurrent or High-Risk Non-Hodgkin LymphomaWho this might be right forAdult Grade III Lymphomatoid GranulomatosisCutaneous B-cell Non-Hodgkin LymphomaExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue+21 more City of Hope Medical Center
Not applicableLooking for participantsNCT06971848What this trial is testingEvaluation of Skin Tests in Biotherapy AllergiesWho this might be right forLocally Advanced Cutaneous Squamous Cell Carcinoma of the Head and NeckMelanoma NeoplasmsSmall Cell Bronchial Carcinomas+13 more University Hospital, Angers 70
Testing effectiveness (Phase 2)Study completedNCT00043420What this trial is testingCPG 7909 in Patients With Cutaneous T-Cell LymphomaWho this might be right forLymphoma, T-Cell, Cutaneous Pfizer 42